Zalunfiban is a novel alpha-IIb beta-3 glycoprotein receptor antagonist developed for the prehospital management of acute myocardial infarction. This category provides access to high-quality Zalunfiban… Read more
Zalunfiban is a novel alpha-IIb beta-3 glycoprotein receptor antagonist developed for the prehospital management of acute myocardial infarction. This category provides access to high-quality Zalunfiban reference standards alongside its identified impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for rigorous analytical method development, impurity profiling, and quality control testing. By incorporating these authentic standards into analytical workflows, researchers can effectively characterize complex drug substance samples, monitor degradation pathways, and ensure regulatory compliance during stability testing and validation. Access to these specific related compounds is essential for maintaining precision in bioanalytical assays and verifying the purity of the active pharmaceutical ingredient throughout the drug development lifecycle.